
Venus Medtech Investor Relations Material
Latest events

H2 2024
28 Mar, 2025

H1 2024
30 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Venus Medtech (Hangzhou) Inc
Access all reports
Venus Medtech Inc. is a medical device company focused on the development and commercialization of transcatheter heart valve products for structural heart diseases. The company's diverse product portfolio encompasses solutions such as the VenusA-valve and VenusP-valve, alongside other devices aimed at addressing conditions related to aortic stenosis and pulmonic, mitral, and tricuspid regurgitation. Venus Medtech has established itself as a leader in the field by continuously focusing on innovations in new materials, bionics, image fusion techniques, and digital sensing to meet the evolving needs of doctors and patients globally. The company is headquartered in Hangzhou, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
2500
Country
🇭🇰 Hong Kong